23499-01-6

Basic information

• Product Name: 4-Piperidinone, 1-(4-nitrophenyl)-
• Synonyms: 4-Piperidinone, 1-(4-nitrophenyl)-;1-(4-NITROPHENYL)PIPERIDINE-4-ONE;1-(4-nitrophenyl)-4-piperidinone
• CAS NO: 23499-01-6
• Molecular Formula: C₁₁H₁₂N₂O₃
• Molecular Weight: 220.22458
• Mol File: 23499-01-6.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-Piperidinone, 1-(4-nitrophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Piperidinone, 1-(4-nitrophenyl)-(23499-01-6)
• EPA Substance Registry System: 4-Piperidinone, 1-(4-nitrophenyl)-(23499-01-6)

Safety Data

• Hazardous Substances Data: 23499-01-6(Hazardous Substances Data)

Usage

General Description

4-Piperidinone, 1-(4-nitrophenyl)- is a chemical compound with the molecular formula C11H13N3O3. It is a nitrophenyl derivative of piperidinone, and is commonly used as an intermediate in the synthesis of various pharmaceuticals and chemicals. It is a pale yellow crystalline solid, and its properties include a melting point of 99-101°C and a boiling point of 378.5°C. The compound is known to be an irritant to the skin, eyes, and respiratory system, and should be handled with caution. Additionally, it is important for proper storage of this compound to prevent exposure to moisture or extreme temperatures, as it can lead to decomposition and degradation of the substance.

Upstream product

• 5382-16-1 4-HYDROXYPIPERIDINE 
• 41661-47-6 piperidin-4-one 
• 100-01-6 4-nitro-aniline 
• 350-46-9 4-Fluoronitrobenzene 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 177-11-7 4,4-ethylenedioxy-piperidine 
• 40064-34-4 piperidine-4,4-diol hydrochloride 
• 41979-39-9 4-piperidone hydrochloride 
• 79421-42-4 8-(4-nitrophenyl)-1,4-dioxa-8-azaspiro[4.5]decane 
• 79421-45-7 4-(4-hydroxypiperidinyl)nitrobenzene 

Downstream Products

• 338413-84-6 2-amino-6-(4-nitrophenyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carbonitrile 
• 1449428-73-2 2,4-dichloro-N-(3-cyano-6-(4-nitrophenyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-5-(morpholinosulfonyl)benzamide 
• 251310-53-9 C₁₃H₁₆N₄O₃ 
• 1073179-88-0 C₁₃H₁₆N₄O₃ 
• 141945-76-8 C₂₂H₂₂N₄O₂ 
• 134348-59-7 C₂₂H₂₂N₄O₂ 
• 79421-45-7 4-(4-hydroxypiperidinyl)nitrobenzene 
• 373360-02-2 methyl 3-[(4-{4-[((2R)-2-hydroxy-2-{4-hydroxy-3-[(methylsulfonyl)amino]phenyl}ethyl)amino]-1-piperidinyl}anilino)sulfonyl]-2-thiophenecarboxylate 
• 373359-59-2 octane-1-sulfonic acid [4-(4-oxo-1-piperidinyl)-phenyl]-amide 
• 373359-62-7 3-[4-(4-oxopiperidin-1-yl)phenylsulfamoyl]thiophene-2-carboxylic acid methyl ester 
• 373359-58-1 butane-1-sulfonic acid [4-(4-oxopiperidin-1-yl)phenyl]amide 
• 391909-33-4 3,5-dichloro-4-(2-chloro-4-nitrophenoxy)-N-{4-[4-({(2S)-2-hydroxy-3-[(2-oxo-2,3-dihydro-1H-benzimidazol-4-yl)oxy]propyl}amino)-1-piperidinyl]phenyl}benzenesulfonamide 
• 391909-29-8 4-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}-N-{4-[4-({(2S)-2-hydroxy-3-[(2-oxo-2,3-dihydro-1H-benzimidazol-4-yl)oxy]propyl}amino)-1-piperidinyl]phenyl}benzenesulfonamide 
• 391909-20-9 N-{[5-({4-[4-({(2S)-2-hydroxy-3-[(2-oxo-2,3-dihydro-1H-benzimidazol-4-yl)oxy]propyl}amino)-1-piperidinyl]anilino}sulfonyl)-thien-2-yl]methyl}benzamide 

Relevant articles and documents

BRAF DEGRADERS

Present invention provides compounds that cause specifically the degradation of BRAF. The present compounds are useful for the treatment of various cancers.

2,4-dibasic miazines compound

The invention belongs to the field of medical chemistry, relates to a 2,4-dibasic miazines compound and specifically relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof, a drug compound thereof and an application thereof in treating EGFR or/and ALK mediated diseases.

PHENYL AMINO PYRIMIDINE BICYCLIC COMPOUNDS AND USES THEREOF

The present invention relates to phenyl amino pyrimidine bicyclic compounds formula (I) which are inhibitors of protein kinases including JAK kinases. In particular the compounds are active against JAK1, JAK2, JAK3 and TYK2 kinases. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.